Zoetis | ZTS - Operating Expenses


Zoetis reported $3.23B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 1000K Jun/2026
Align Technology USD 864.87M 2.84M Jun/2026
Bayer EUR 9.88B 452M Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Coherus Biosciences USD 51.83M 2.48M Dec/2025
Dentsply International USD 1.32B 895M Mar/2026
Eli Lilly USD 10.52B 496M Jun/2026
Henry Schein USD 3.26B 84M Jun/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Illumina USD 899M 47M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
J&J USD 17.83B 388M Jun/2026
Laboratory Of America USD 3.27B 146.9M Jun/2026
Merck USD 15.77B 2.4B Jun/2026
Neogen USD 222.2M 7.7M Mar/2026
Pacira USD 180.54M 7.79M Jun/2026
Perrigo USD 290.5M 645.1M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Quest Diagnostics USD 2.58B 88M Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Sanofi EUR 8.98B 1.73B Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026